• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Dendreon Corp

+ Add to Watchlist

DNDN:US

0.9795 USD 0.0505 4.90%

As of 20:10:00 ET on 10/31/2014.

Company Profile for Dendreon Corp (DNDN)

Dendreon Corporation discovers and develops immunologically based therapeutic products for the treatment of cancer. The Company combines knowledge in immunology and antigen engineering with proprietary cell separation technologies to develop therapeutic vaccines that induce cell-mediated immunity, the body's key defense against cancer.

Contact Information

Dendreon Corp

1301 2nd Avenue
Seattle, WA 98101
United States
Phone: 1-206-256-4545
Fax: 1-206-256-0571

Key Executives for Dendreon Corp (DNDN)

Douglas G Watson "Doug"ChairmanW Thomas Amick "Tom"President/CEO
Andrew S SandlerExec VP/Chief Medical OfficerGregory R CoxInterim CFO/VP:Finance
Lindsay RoccoExec VP:Corporate CommunicationsWilliam MonteithExec VP:Technical Operations
Bill JenkinsonVP/Chief Marketing OfficerSilvio PachecoVP/Chief Customer Officer
Robert CrottyVP/Interim Secy & Gen CnslKaren E BrophyVP/Head:Human Resources

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil